Asston Pharmaceuticals Limited

BSE: 544445
Asston Pharmaceuticals Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24304MH2019PLC324187 Incorporated 16 April 2019 ROC Mumbai HQ Thane, Maharashtra, India
Active Listed - BSE: 544445 Public Limited Company pharma
Data last updated
Market Cap
₹135 Cr
APL · BSE
Share Price
₹130.12
+4.99% today
Revenue
₹25.47 Cr
FY 2025-26 · +1.7% YoY
EBITDA
−₹0.56 Cr
Margin -2.2%
Net Profit
₹3.93 Cr
FY 2025-26 · +3.4% YoY
P/E (TTM)
33.1x
P/B 1.9x
ROE
15.5%
ROCE 16.7%
Debt / Equity
0.25
Interest cover -71.6x

About Asston Pharmaceuticals Limited

Data last updated:

Asston Pharmaceuticals Limited is a public limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 April 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PLC324187. Its GSTIN is 27AASCA1841Q1Z0 (Maharashtra). It is a listed company as per MCA records. Its shares are listed on BSE: 544445.

The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹10.92 Cr. It is led by directors including Ashish Narayan Sakalkar (Managing Director) and Saili Jayaram More (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Thane, Maharashtra.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹25.47 Cr, a growth of 1.7% compared to the previous year. For the same year it recorded a net profit of ₹3.93 Cr (net margin 15.4%) and EBITDA of -₹56 Lakh (EBITDA margin -2.2%). The net worth stands at ₹38.86 Cr (up 252.3% YoY). Total assets are valued at ₹44.13 Cr (up 139.2% YoY).

As per MCA filings, the company has open charges of ₹3.11 Cr and satisfied charges of ₹4.75 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 14 deals on record (13 market trades, 1 ipo); the latest was in September 2026.

Company details

CIN U24304MH2019PLC324187
Registration Number 324187
Incorporation Date 16 April 2019
ROC Mumbai
Listing Status Listed - Listed on BSE (544445)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026

CIN history

Asston Pharmaceuticals has one previous CIN (Corporate Identification Number): U24304MH2019PTC324187. The current CIN is U24304MH2019PLC324187, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24304MH2019PLC324187Current
U24304MH2019PTC324187Previous
Key People
Ashish Narayan Sakalkar Managing Director Saili Jayaram More Whole-Time Director Yogesh Prakash Supekar Director

Contact details

Asston Pharmaceuticals Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    4th Floor Office No A – 431 Balaji Bhavan, Plot No 42A Sector – 11 CBD Belapur Navi Mumbai, Thane, Maharashtra, India – 400614
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Asston Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Asston Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Asston Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Asston Pharmaceuticals Limited, buy the company report.

Financials of Asston Pharmaceuticals Limited

FY 2025-26 filings available

Asston Pharmaceuticals Limited reported revenue of ₹25.47 Cr (up 1.7% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹25.47 Cr
+1.7% YoY
EBITDA
−₹0.56 Cr
-110.3% YoY
Profit After Tax
₹3.93 Cr
+3.4% YoY
Net Worth
₹38.86 Cr
+252.3% YoY
Total Assets
₹44.13 Cr
+139.2% YoY
Total Debt
₹5.10 Cr
-29.8% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue25.4725.0416.036.549.60
Revenue growth+1.7%+56.2%+145.1%-31.9%-
EBITDA(0.56)5.453.821.52(0.35)
EBITDA margin-2.2%+21.8%+23.8%+23.2%-3.7%
Profit before tax4.615.033.251.410.17
Net profit3.933.802.431.050.12
Net profit margin+15.4%+15.2%+15.2%+16.1%+1.3%
EPS (₹)4.546.1431.0115.091.58
Balance sheet
Total assets44.1318.4514.007.304.29
Net worth38.8611.037.181.990.93
Total debt5.107.266.825.243.31
Cash & bank1.290.200.010.120.14
Net working capital33.1617.3512.364.322.20
Cash flow
Cash from operations(10.18)(0.03)(3.97)(0.32)(1.19)
Cash from investing(9.91)0.73(0.01)(0.91)0.00
Cash from financing21.18(0.51)3.861.211.29

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 23 Oct 2026
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue25.4725.0416.036.549.60
Revenue growth+1.7%+56.2%+145.1%-31.9%-
Other income6.120.570.250.650.96
Total expenses26.0319.5912.215.029.95
Employee cost1.621.060.190.230.26
EBITDA(0.56)5.453.821.52(0.35)
EBITDA margin-2.2%+21.8%+23.8%+23.2%-3.7%
Depreciation0.320.040.060.040.01
Interest0.630.950.760.720.43
Profit before tax4.615.033.251.410.17
Tax0.731.160.820.360.05
Net profit3.933.802.431.050.12
Net profit margin+15.4%+15.2%+15.2%+16.1%+1.3%
EPS (₹)4.546.1431.0115.091.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital8.516.270.780.700.70
Reserves & surplus30.354.766.401.290.23
Shareholders' funds (net worth)38.8611.037.181.990.93
Secured loans3.174.533.884.052.96
Unsecured loans1.932.732.941.190.35
Total debt5.107.266.825.243.31
Total liabilities44.1318.4514.007.304.29
Assets
Gross block11.051.101.201.190.94
Net block10.690.960.971.130.91
Capital work in progress0.000.000.000.000.00
Investments0.000.000.000.000.00
Inventories0.770.721.441.500.50
Sundry debtors36.5724.5516.728.616.40
Cash & bank balances1.290.200.010.120.14
Loans & advances1.961.550.860.460.34
Total current assets40.5927.0219.0310.697.38
Total current liabilities7.439.676.676.375.18
Net working capital33.1617.3512.364.322.20
Total assets44.1318.4514.007.304.29
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash0.200.010.120.140.03
Net cash from operating activities(10.18)(0.03)(3.97)(0.32)(1.19)
Net cash from investing activities(9.91)0.73(0.01)(0.91)0.00
Net cash from financing activities21.18(0.51)3.861.211.29
Net change in cash1.090.19(0.12)(0.01)0.10
Closing cash1.290.200.010.120.14
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+1.7%+56.2%+145.1%-31.9%-
EBITDA growth-110.3%+42.7%+151.3%+534.3%-
PBT growth-8.4%+54.8%+130.5%+729.4%+9997.0%
Net income growth+3.4%+56.4%+131.4%+775.0%-
Revenue CAGR (3Y)+57.3%+37.7%---
Profitability & leverage
Net income margin+15.2%+15.5%+15.2%+16.1%+1.3%
Return on capital employed+16.7%+36.7%+37.7%+36.9%+13.8%
Return on net worth+15.5%+42.3%+53.0%+72.6%+11.8%
Debt / equity0.250.771.322.933.56
Long-term debt / equity0.120.210.380.941.01
Interest cover-71.5917.5620.2148.65-119.44
Efficiency & per share
Fixed asset turnover4.1921.7713.416.1410.21
Inventory turnover34.1923.1910.906.5419.20
Debtors turnover0.831.211.270.871.50
EPS (₹)4.546.1431.0115.091.58
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)45.6517.6091.6328.3713.28

To see the full year-wise statements and ratios of Asston Pharmaceuticals Limited, buy the company report.

Board of directors of Asston Pharmaceuticals Limited

Asston Pharmaceuticals has 8 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashish Narayan Sakalkar
Also directs: Ferron Lifecare Private Limited
Managing Director16 Apr 20197 Years 6 MonthsCurrent
Saili Jayaram MoreWhole-Time Director16 Apr 20197 Years 6 MonthsCurrent
Yogesh Prakash SupekarDirector16 Oct 20251 Years 0 MonthsCurrent
Rishabh Kumar Jain
Also directs: Modern Diagnostic & Research Centre Limited
Director20 Sep 20242 Years 1 MonthsCurrent
Vijaya E Shahapurkar
Also directs: Delta Galaxy Engineering Services Limited
Director20 Sep 20242 Years 1 MonthsCurrent
Sachin Chandrakant Badakh
Also directs: Ferron Lifecare Private Limited
Director17 May 20242 Years 5 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Auditor

Asston Pharmaceuticals Limited is audited by Doshi Doshi & Co for the financial year 2025.

Auditor firmFinancial yearFirm registration number
Doshi Doshi & CoFY 2025153683W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 50.70%, foreign institutional investors hold 1.90%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 47.40%.

Promoters: 50.70%FII (Foreign Institutional): 1.90%Retail & Others: 47.40%
Sep 2026
QUARTER
50.70% Promoters
1.90% FII (Foreign Institutional)
47.40% Retail & Others
Promoter holding - history
Now 50.70% · Sep 2026High 50.70% · Mar 2026Low 50.70% · Mar 2026
49%49.8%50.5%51.3%52%Mar 2026Jun 2026Sep 2026Mar 2026: 50.70%Jun 2026: 50.70%Sep 2026: 50.70%50.70%50.70%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026
Promoters50.70%50.70%50.70%
Public49.30%49.30%49.30%

Charges & borrowings

Open charges
₹3.11 Cr
Satisfied charges
₹4.75 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹3.11 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jan 2026101237831Hdfc Bank Limited₹18 LakhOpen
23 Jan 2026101237833Hdfc Bank Limited₹23.7 LakhOpen
16 Jan 2026101232211Hdfc Bank Limited₹24 LakhOpen
09 Jan 2026101228705Hdfc Bank Limited₹24 LakhOpen
30 Oct 2025101190397Hdfc Bank Limited₹2.21 CrOpen

To see the full charge records of Asston Pharmaceuticals Limited, buy the company report.

Total charge records: 10 View all charges

Deals & funding

Asston Pharmaceuticals Limited has 14 deals on record (13 market trades, 1 ipo); the latest was in September 2026.

Total deals
14
Market trades
13
IPO
1

Deals on record (5 of 14)

WhenDealAmountParties
Sep 2026Market trade₹62.8 LakhBuyer: an individual
Aug 2026Market trade₹1.75 CrBuyer: 2 individuals
Aug 2026Market trade₹1.85 CrBuyer: an individual
Aug 2026Market trade₹2.49 CrBuyer: an individual
Jul 2025Market trade₹64.2 LakhSeller: JSK Securities and Services Private Limited

To see the full deal history of Asston Pharmaceuticals Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Asston Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Asston Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AASCA1841Q1Z0MaharashtraActive05 Aug 2019

To see the full GST registrations and return filing status of Asston Pharmaceuticals Limited, buy the company report.

Recent activity

Asston Pharmaceuticals Limited has 11 board changes on record since 2019: 9 appointments and 2 cessations. The latest: Sandip Sharma was appointed as Director on 30 Mar 2026.

Filing
Asston Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Appointed
Sandip Sharma was appointed as Director.
Appointed
Yashvardhan Nitin Tupe was appointed as Director.
Charges
A charge registered on 30 Jul 2022 via Charge ID 100618839 with Others was fully satisfied on 16 Feb 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 101237831 was registered on 27 Jan 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.24 Cr with Charge ID 101237833 was registered on 23 Jan 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.24 Cr with Charge ID 101232211 was registered on 16 Jan 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.24 Cr with Charge ID 101228705 was registered on 09 Jan 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.21 Cr with Charge ID 101190397 was registered on 30 Oct 2025.
Appointed
Yogesh Prakash Supekar was appointed as Director.
AGM
Asston Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Appointed
Deven Manohar Patil was appointed as CFO.

18 earlier events are in the company report.

News

Frequently asked questions

Asston Pharmaceuticals is an active public limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 April 2019 (7+ years old) and is registered under CIN U24304MH2019PLC324187. Listed on BSE: 544445.

Asston Pharmaceuticals reported revenue of ₹25.47 Cr for FY 2025-26 (up 1.7% YoY) based on standalone financials.

Asston Pharmaceuticals has 8 current directors:

The latest financial statements of Asston Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Asston Pharmaceuticals is 27AASCA1841Q1Z0, registered in Maharashtra.

The CIN (Corporate Identification Number) of Asston Pharmaceuticals is U24304MH2019PLC324187. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Asston Pharmaceuticals is a listed company as per MCA records. Its shares are listed on BSE (code: 544445).

Asston Pharmaceuticals has 2 court cases on record: 2 filed against it. Most are in the district courts.

Asston Pharmaceuticals was incorporated on 16 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.

Asston Pharmaceuticals has 14 deals on record (13 market trades, 1 ipo); the latest was in September 2026.